A successful exit & game-changing tech for early diagnosis of dementia
We kicked off June with the news of our successful exit from fulfilmentcrowd, following the company's impressive global expansion. Also announced this month:
We included all the details in our latest edition of the BGF Newsletter, alongside some of our top news and insights from recent months, in case you missed them:
Looking for more? Explore all our news, views and resources here.
Unlocking fulfilmentcrowd's international growth 🌎
fulfilmentcrowd is a Lancashire-based global e-commerce fulfilment and logistics business. With support from our team, the company has achieved significant expansion across Europe and North America. And it’s now secured a majority investment from mid-market PE firm Palatine. As part of the deal, we successfully exited the business — reinvesting for a minority stake, to continue backing fulfilmentcrowd through this next phase of its growth.
Oxford Brain Diagnostics (OBD) commences roll out 🧠
With over 55 million people currently living with dementia globally — a number expected to nearly double every 20 years — Oxford Brain Diagnostics Ltd's technology offers a breakthrough solution for early diagnosis. We're proud to have supported OBD's remarkable progress over the past two years. And following regulatory approvals, the business will now begin the commercial roll out of its software to the US and UK healthcare sectors.
Subscribe to the BGF Newsletter here to be emailed our full monthly updates, designed for scaleup founders, leaders and advisors across the UK.
fulfilmentcrowd Oxford Brain Diagnostics Ltd PMC